HCV-话题@MedSci

#HCV#

247篇内容 | 2502人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257780, encodeId=6c89125e780fd, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=CLIN CHEM LAB MED：使用灵活的分子病毒学方法对血浆中的方法进行验证并在脑脊液中进行验证:建立HIV、HBV和HCV Aptima™Quant Dx检测, objectType=article, longId=190211, objectId=2ea819021176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ea819021176, replyNumber=0, likeNumber=56, createdTime=2020-03-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ea819021176, moduleTitle=CLIN CHEM LAB MED：使用灵活的分子病毒学方法对血浆中的方法进行验证并在脑脊液中进行验证:建立HIV、HBV和HCV Aptima™Quant Dx检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ea819021176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257779, encodeId=fbee125e7795c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=BMJ：HCV早发现早治疗策略 (HepCATT)的成本效益研究, objectType=article, longId=188998, objectId=74af188998fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74af188998fd, replyNumber=0, likeNumber=56, createdTime=2020-03-01, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74af188998fd, moduleTitle=BMJ：HCV早发现早治疗策略 (HepCATT)的成本效益研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74af188998fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257778, encodeId=cf5b125e77846, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatology：慢性HBV合并感染HCV患者直接作用抗病毒治疗后的乙肝相关结局分析, objectType=article, longId=188596, objectId=5eaa1885960b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eaa1885960b, replyNumber=0, likeNumber=49, createdTime=2020-02-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eaa1885960b, moduleTitle=J Hepatology：慢性HBV合并感染HCV患者直接作用抗病毒治疗后的乙肝相关结局分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eaa1885960b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257777, encodeId=fec7125e7779e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, objectType=article, longId=187606, objectId=e3cd18e60695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3cd18e60695, replyNumber=0, likeNumber=38, createdTime=2020-02-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3cd18e60695, moduleTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3cd18e60695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257776, encodeId=cf9f125e776a2, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Clinica Chimica Acta：关于目前抗hcv检测的信号截止比和补充检测新算法的建议, objectType=article, longId=184056, objectId=af27184056c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af27184056c6, replyNumber=0, likeNumber=50, createdTime=2019-12-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af27184056c6, moduleTitle=Clinica Chimica Acta：关于目前抗hcv检测的信号截止比和补充检测新算法的建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af27184056c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257775, encodeId=0068125e77540, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：HCV根除后肝癌风险研究, objectType=article, longId=182467, objectId=5ff718246e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ff718246e0c, replyNumber=0, likeNumber=51, createdTime=2019-11-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ff718246e0c, moduleTitle=Gastroenterology：HCV根除后肝癌风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ff718246e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257774, encodeId=0fa2125e77478, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：HCV3型患者索非布韦治疗响应低相关因素研究, objectType=article, longId=178655, objectId=00931e865521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00931e865521, replyNumber=0, likeNumber=35, createdTime=2019-09-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00931e865521, moduleTitle=Gastroenterology：HCV3型患者索非布韦治疗响应低相关因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00931e865521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257773, encodeId=c7b8125e77309, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：Glecaprevir/Pibrentasvir用于索非布韦治疗失败HCV患者, objectType=article, longId=177584, objectId=0d391e7584b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d391e7584b3, replyNumber=0, likeNumber=28, createdTime=2019-08-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d391e7584b3, moduleTitle=Gastroenterology：Glecaprevir/Pibrentasvir用于索非布韦治疗失败HCV患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d391e7584b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257772, encodeId=0d40125e77298, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：DAAs与HCV患者肝癌死亡风险, objectType=article, longId=177065, objectId=79271e70654c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79271e70654c, replyNumber=0, likeNumber=33, createdTime=2019-08-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79271e70654c, moduleTitle=Gastroenterology：DAAs与HCV患者肝癌死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79271e70654c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257771, encodeId=f675125e771c5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, objectType=article, longId=176003, objectId=fb721e600347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb721e600347, replyNumber=0, likeNumber=35, createdTime=2019-07-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb721e600347, moduleTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb721e600347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257770, encodeId=1afc125e770ad, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=BMC Gastroenterol：丙肝患者容易高血糖，清除HCV可降低血糖并改善胰岛素抵抗, objectType=article, longId=174551, objectId=9f5a1e455198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5a1e455198, replyNumber=0, likeNumber=31, createdTime=2019-07-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5a1e455198, moduleTitle=BMC Gastroenterol：丙肝患者容易高血糖，清除HCV可降低血糖并改善胰岛素抵抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5a1e455198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257769, encodeId=192a125e769eb, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译, objectType=article, longId=165181, objectId=c57c16518139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57c16518139, replyNumber=0, likeNumber=20, createdTime=2019-04-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57c16518139, moduleTitle=《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c57c16518139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257768, encodeId=20a9125e76857, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：HCV感染供体的心肺移植, objectType=article, longId=165027, objectId=304816502e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=304816502e50, replyNumber=0, likeNumber=32, createdTime=2019-04-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=304816502e50, moduleTitle=NEJM：HCV感染供体的心肺移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=304816502e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257767, encodeId=ebff125e767e7, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, objectType=article, longId=163131, objectId=90c11631319d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c11631319d, replyNumber=0, likeNumber=42, createdTime=2019-03-29, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c11631319d, moduleTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90c11631319d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257766, encodeId=3f9e125e76660, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=2019逆转录病毒和机会性感染会议CROI报道：感染HCV后接受直接抗病毒药物治疗的患者患糖尿病的风险降低, objectType=article, longId=162026, objectId=2cee16202637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cee16202637, replyNumber=0, likeNumber=28, createdTime=2019-03-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cee16202637, moduleTitle=2019逆转录病毒和机会性感染会议CROI报道：感染HCV后接受直接抗病毒药物治疗的患者患糖尿病的风险降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cee16202637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257765, encodeId=bc71125e76568, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet：抗病毒治疗对HCV患者临床结局的影响, objectType=article, longId=160028, objectId=342516002873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=342516002873, replyNumber=0, likeNumber=36, createdTime=2019-02-16, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=342516002873, moduleTitle=Lancet：抗病毒治疗对HCV患者临床结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=342516002873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257764, encodeId=55f3125e764d2, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险, objectType=article, longId=159339, objectId=4c75159339c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c75159339c3, replyNumber=0, likeNumber=27, createdTime=2019-02-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c75159339c3, moduleTitle=Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c75159339c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257763, encodeId=4c65125e76357, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=28, createdTime=2019-01-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257762, encodeId=b658125e762ae, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, objectType=article, longId=156075, objectId=86e41560e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86e41560e596, replyNumber=0, likeNumber=35, createdTime=2018-12-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86e41560e596, moduleTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86e41560e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257761, encodeId=b60b125e761dc, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？, objectType=article, longId=154373, objectId=b0f71543e37a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0f71543e37a, replyNumber=0, likeNumber=39, createdTime=2018-11-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0f71543e37a, moduleTitle=Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0f71543e37a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

CLIN CHEM LAB MED：使用灵活的分子病毒学方法对血浆中的方法进行验证并在脑脊液中进行验证:建立HIV、HBV和HCV Aptima™Quant Dx检测

2020-03-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

BMJ：HCV早发现早治疗策略 (HepCATT)的成本效益研究

2020-03-01

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatology：慢性HBV合并感染HCV患者直接作用抗病毒治疗后的乙肝相关结局分析

2020-02-24

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张

2020-02-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

Clinica Chimica Acta：关于目前抗hcv检测的信号截止比和补充检测新算法的建议

2019-12-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：HCV根除后肝癌风险研究

2019-11-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：HCV3型患者索非布韦治疗响应低相关因素研究

2019-09-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：Glecaprevir/Pibrentasvir用于索非布韦治疗失败HCV患者

2019-08-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：DAAs与HCV患者肝癌死亡风险

2019-08-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率

2019-07-24

ymljack (审核中...)

前往app查看评论内容

#HCV#

BMC Gastroenterol：丙肝患者容易高血糖，清除HCV可降低血糖并改善胰岛素抵抗

2019-07-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译

2019-04-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：HCV感染供体的心肺移植

2019-04-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在

2019-03-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

2019逆转录病毒和机会性感染会议CROI报道：感染HCV后接受直接抗病毒药物治疗的患者患糖尿病的风险降低

2019-03-12

柳叶一刀 (审核中...)

前往app查看评论内容

#HCV#

Lancet：抗病毒治疗对HCV患者临床结局的影响

2019-02-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险

2019-02-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析

2019-01-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异

2018-12-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

Am J Transplant：HCV已故者肾脏供HCV阴性者进行移植具成本效果吗？

2018-11-27

科室
- - 订阅+
  - 更多科室
工具
服务